Post-COVID Smell Loss: How Anosmia Recovers, When to See a Doctor

The COVID-19 pandemic has become the most common new cause of anosmia. Before the pandemic, classical causes included viral upper respiratory infection (post-viral anosmia), head trauma, nasal polyps, ageing. COVID-19 reshaped this landscape.

Mechanism: the SARS-CoV-2 virus targets cells expressing the ACE2 receptor. Olfactory epithelium (the smell tissue on the roof of the nasal cavity) — especially sustentacular (support) cells — has high ACE2 expression. The virus infects these cells, causing inflammation that disrupts olfactory receptor neuron function.

COVID anosmia differs from other post-viral anosmias: 1) Rapid onset (hours to days), 2) Usually no nasal obstruction (unlike anosmia from a cold where the nose is blocked), 3) Variable recovery (1 week to permanent), 4) Parosmia (distorted smell) is more common.

For newer variants (Omicron and later) the smell-loss rate is lower than earlier (Alpha 70%, Omicron 30%). Still a major problem, particularly in prolonged cases. We expand on the clinical framework in our general ENT services.

80% fast recoverers: anosmia begins during or shortly after COVID infection; full recovery in 1-3 weeks. No specific treatment; observation suffices.

10-15% prolonged: anosmia persists at 4-6 weeks. ENT evaluation is indicated. Treatment options: 1) Olfactory training — 2× daily with 4 sharp scents (rose, lemon, eucalyptus, clove oil are the classic set), smelling each 15-20 seconds while thinking of the name; for 12-24 weeks. 2) Short-course oral corticosteroid (prednisone) — selected cases with concurrent nasal inflammation. 3) Intranasal corticosteroid spray. 4) Omega-3 supplementation (anti-inflammatory, neuron regeneration).

5% permanent: anosmia >6 months. Likely permanent neural damage, but olfactory training can continue (some recover even at 12-18 months). Structural causes (polyps, anatomy) must be excluded.

Parosmia window: many patients experience parosmia (distorted smell) during recovery — smells are perceived wrongly. Classic complaint: "coffee, meat, garlic smell like rubbish". Distressing but actually part of recovery; receptor neurons re-wiring create faulty signals. Parosmia typically lasts 3-12 months then resolves.

Olfactory training (OT) is the one evidence-based treatment for prolonged post-COVID anosmia. Mechanism: olfactory receptor neurons (in the olfactory bulb) are plastic and can re-organise with repeated stimulation. Like physical therapy for muscle recovery.

Practical application: 1) Build a kit — 4 small bottles (15-20 mL) of 4 essential oils: rose (floral), lemon (citrus), eucalyptus (menthol-like), clove oil (spicy). The classic worldwide "rose-lemon-eucalyptus-clove" combination. Alternatively rotate to other scents at 6 months.

2) Twice daily (morning + evening) smell each bottle 15-20 seconds, close your eyes and think of the name + how it used to smell — to strengthen cortical connection. Total time 5-7 minutes daily.

3) Duration: minimum 12 weeks, optimal 24 weeks (6 months). Some patients continue 1 year. Regularity is critical — once daily or every few days is ineffective.

Effectiveness: cohort studies show 30-50% improvement (15-20% extra improvement over control). Modest but the only proven medical treatment, so recommended in all prolonged cases.

Practical reminders: mobile apps (AbScent, Smell App) help with reminders + tracking progress. Our clinic coordinator sends weekly WhatsApp reminders to patients.

Oral corticosteroid (prednisone): for selected cases. Indication: post-COVID anosmia >4-6 weeks with acute nasal inflammation (allergic rhinitis flare, sinusitis). Dose: 30-40 mg/day for 5-7 days then rapid taper. Manage hypertension, diabetes, gastritis. Adds 20-30% improvement in eligible cases. Not routine for isolated COVID anosmia.

Intranasal corticosteroid spray (mometasone, fluticasone): general anti-inflammatory effect. 1 puff per nostril daily, 8-12 weeks. No side effects. Insufficient alone but supports olfactory training.

Omega-3 (fish oil): anti-inflammatory + neuron regeneration. 1-2 g/day (EPA + DHA total) for 12-24 weeks. Some cohort studies show 15-20% extra benefit on top of olfactory training. Low side-effect profile.

Vitamin A (palmitate): introduced for neuron health; more research needed. Excess is toxic (especially in pregnancy); should not be used without clinical advice.

Alpha-lipoic acid, theophylline, platelet-rich plasma: small studies exist but no large RCT. Not routine.

Practical decision: first-line for prolonged post-COVID anosmia is olfactory training + intranasal spray + omega-3. Selected cases get short-course oral corticosteroid. Other treatments — insufficient evidence.

Smell loss is not just about food enjoyment — it has significant quality-of-life and safety consequences. The impact is much greater than people predict.

Safety risks: 1) Cannot detect fire — smoke is unscented to the patient. Detector installation is MANDATORY (not common in Türkiye homes but essential). 2) Gas leak — natural gas odorant is unscented to the patient; explosion risk. Carbon monoxide detector adds protection. 3) Spoiled food — cannot tell expired or rotten food. Practical: discipline with dates, visual check (mould). 4) Personal hygiene — body odour, urine, faecal smell undetectable; social problem possible.

Nutrition: 60% of anosmia patients have reduced appetite and weight loss. Reason: 80% of taste is actually smell (retronasal olfaction); without smell food becomes "tasteless". Solution: texture and temperature variety, spicing (hot, sour, salty — perceived through taste receptors, not smell).

Psychological impact: anosmia raises depression risk 2-3×. Reasons: lost food enjoyment, reduced pleasure in social events (shared meals, perfume), inability to smell a partner (intimacy), lost memory triggers ("grandmother's cooking smell"). Even mild anosmia, when prolonged, has meaningful psychological impact.

Support groups: AbScent (international), local WhatsApp groups growing in Türkiye. Professional psychological support is sometimes needed. More detail: sinusitis page.

Short-term (1-3 week) post-COVID anosmia does not need a doctor visit; it resolves spontaneously. ENT or neurology evaluation is recommended for:

1) Anosmia >4-6 weeks — to begin olfactory training. 2) Anosmia + nasal obstruction — exclude structural causes (septal deviation, polyps, chronic sinusitis). 3) Unilateral anosmia — rarely intracranial pathology (tumour, cyst) — MRI recommended. 4) Anosmia + headache + neurologic signs — neurology evaluation. 5) Paediatric anosmia — rare; exclude congenital anomaly. 6) Severe parosmia seriously affecting quality of life.

ENT exam contents: 1) Detailed history (onset, duration, accompanying signs), 2) Nasal endoscopy (evaluate the olfactory cleft — site of olfactory epithelium at the roof of the nasal cavity), 3) Smell test (objective — UPSIT, Sniffin' Sticks standardised tests), 4) MRI (in specific cases — tumour, asymmetric anosmia).

Onward referral: after ENT, as needed — nutrition (weight loss management), psychology (depression support), neurology (associated symptoms).

Cases with persistent symptoms beyond 12 weeks after COVID infection are classified as "Long COVID". Anosmia/parosmia are among the most common Long COVID symptoms — persisting in 20-30% of patients. Other Long COVID symptoms: fatigue, "brain fog", shortness of breath, joint pain, palpitations, headache.

Mechanism: persistent viral reservoir, chronic immune response, microvascular damage, autoimmune reactions. Olfactory bulb MRI in prolonged cases shows small structural changes.

Treatment of Long COVID anosmia: olfactory training (at least 6 months), corticosteroid (selected), omega-3, vitamin support, multidisciplinary approach (ENT + neurology + nutrition + psychology).

Long COVID patient groups: in Türkiye "Long COVID Türkiye" platform; internationally "Long COVID Support" — for sharing experiences and support.

Vaccine effect: COVID vaccines (mRNA, inactivated) reduce anosmia frequency by 50% in post-vaccine breakthrough infections. Also reduce Long COVID risk (~30-50% per studies). Vaccination matters.

Practical tips for living with anosmia: We share patient experiences on our Istanbul ENT services.